Effect of Cellular Quiescence on CML Therapy
Author Information
Author(s): Komarova Natalia L., Wodarz Dominik
Primary Institution: University of California Irvine
Hypothesis
How does cellular quiescence influence the success of targeted therapy in chronic myelogenous leukemia (CML)?
Conclusion
Cellular quiescence affects the kinetics of CML treatment response and the emergence of drug-resistant mutants.
Supporting Evidence
- Cellular quiescence can shield cancer cells from drug treatment.
- Different patterns of tumor cell decline were observed during treatment.
- Quiescence increases the likelihood of drug-resistant mutants when using multiple drugs.
Takeaway
Some cancer cells can take a break from growing, which makes it harder to treat the cancer with drugs. This study looks at how this break affects treatment success.
Methodology
Mathematical modeling of tumor cell dynamics under treatment with targeted inhibitors.
Limitations
The model may not account for all biological complexities present in actual patient scenarios.
Participant Demographics
Patients with chronic myelogenous leukemia (CML).
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website